A sample is a small part or quantity intended to show what the whole is like. Samples can be taken to study scientific data and/or populations.
-
JUN 06, 2023 | 8:00 AM
C.E. CREDITS
As the life sciences industry continues to evolve, so does the need for advanced laboratory management solutions that can help improve efficiency, streamline workflows, and ensure compliance...
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the developme...
Date: May 11, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Quantitative genetic analysis plays a critical role in the research and development of novel biotherapeutics and vaccines....
Affinite Instruments is a developer and supplier of SPR analysis instruments, related consumables, and software. Focusing on the mission of SPR for everyone, this webinar will review the ben...
Date: April 26, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) The heart is a 380-million-year-old organ, yet we do not have a complete understanding of the molecular landscape in the...
APR 25, 2023 | 10:00 AM
C.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) A liquid biopsy is a non-invasive alternative to a surgical biopsy that enables researchers to learn a range of infor...
Date: April 13, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) It is important to confirm the sequences and post-translational modifications (PTMs) of protein therapeutics to ensure d...
APR 12, 2023 | 8:00 AM
C.E. CREDITS
Date: April 12, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Recombinant adeno-associated viruses (AAVs), lentiviral vectors (LVV), and adenoviru...
APR 05, 2023 | 1:00 PM
C.E. CREDITS
Date: April 04, 2023 Time: 10:00pm (PDT), Date: April 05, 2023 Time: 2:00am (EDT), 7:00am (CEST), 1:00pm (SGT) This seminar provides an overview of fluorescence microscopy in cancer research...
Prof. Hofman will present results of a multi-centric study evaluating performance of new Oncomine Dx Express Test, CE IVD for genomic profiling of cancer patient samples. The data cover perf...
In her presentation Prof. Staebler will share data generated by new Genomic Assessment Metrics (GIM) software for HRD assessment, and Oncomine Comprehensive Assay Plus. The samples tested we...
MAR 30, 2023 | 12:25 PM
C.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...